About Us

Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep inequities have persisted across our pharmaceutical, biotechnology, and medical systems. Despite increased public attention on the problem in recent years, progress remains far too slow. 

At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting underserved communities. By financing the development of drugs and treatments addressing the world’s greatest health disparities, we are convinced that we can accelerate health equity globally and achieve strong financial returns for our investors.


Squire Servance
Kamil Ali-Jackson
Veleka Peeples-Dyer
Joshua Adeoye, MD
Christopher Whitfield

Advisory Board

Charles Corpening
Ben Duster
Anindya Roychowdhury
Ric Ramsey
Owen May
Owen May
Dr. Ted W. Love